Gene Symbol | Gene ID | Gene Info |
---|---|---|
EP300
|
ENSG00000100393.9 | E1A binding protein p300 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr22_41487816_41488241 | EP300 | 238 | 0.703455 | -0.40 | 2.9e-01 | Click! |
chr22_41486838_41487071 | EP300 | 836 | 0.444808 | -0.26 | 5.1e-01 | Click! |
chr22_41487155_41487362 | EP300 | 532 | 0.611224 | 0.06 | 8.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_21462508_21463481 | 0.69 |
NEBL-AS1 |
NEBL antisense RNA 1 |
51 |
0.59 |
chr1_180881914_180882730 | 0.65 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr19_45995836_45996758 | 0.63 |
RTN2 |
reticulon 2 |
228 |
0.87 |
chr11_131780761_131781452 | 0.61 |
NTM |
neurotrimin |
209 |
0.95 |
chr1_68697735_68698156 | 0.59 |
WLS |
wntless Wnt ligand secretion mediator |
18 |
0.98 |
chr8_15397591_15398115 | 0.59 |
TUSC3 |
tumor suppressor candidate 3 |
61 |
0.98 |
chr14_105436556_105437076 | 0.57 |
AHNAK2 |
AHNAK nucleoprotein 2 |
7878 |
0.16 |
chr6_46702576_46703631 | 0.56 |
PLA2G7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
24 |
0.97 |
chr11_706564_706815 | 0.55 |
EPS8L2 |
EPS8-like 2 |
60 |
0.94 |
chr20_9048816_9049419 | 0.55 |
PLCB4 |
phospholipase C, beta 4 |
293 |
0.9 |
chr1_81703498_81704139 | 0.54 |
ENSG00000223026 |
. |
13656 |
0.28 |
chr22_30831807_30831958 | 0.53 |
MTFP1 |
mitochondrial fission process 1 |
10077 |
0.07 |
chr18_11149170_11149978 | 0.51 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
987 |
0.72 |
chr20_23617810_23618640 | 0.48 |
CST3 |
cystatin C |
357 |
0.87 |
chr17_36610454_36610862 | 0.48 |
ENSG00000260833 |
. |
1970 |
0.27 |
chr4_121842864_121843514 | 0.46 |
PRDM5 |
PR domain containing 5 |
815 |
0.75 |
chr14_88789378_88789974 | 0.46 |
KCNK10 |
potassium channel, subfamily K, member 10 |
83 |
0.98 |
chr14_79745937_79746359 | 0.44 |
NRXN3 |
neurexin 3 |
101 |
0.98 |
chr4_30719321_30719743 | 0.42 |
PCDH7 |
protocadherin 7 |
2505 |
0.43 |
chr13_98866468_98866619 | 0.41 |
ENSG00000263399 |
. |
5765 |
0.17 |
chr9_129884150_129884930 | 0.41 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr17_43249136_43249303 | 0.40 |
RP13-890H12.2 |
|
268 |
0.83 |
chr3_149374149_149374556 | 0.40 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
455 |
0.65 |
chr18_31020374_31020722 | 0.40 |
CCDC178 |
coiled-coil domain containing 178 |
109 |
0.98 |
chr8_122653551_122653742 | 0.40 |
HAS2 |
hyaluronan synthase 2 |
16 |
0.5 |
chr13_100608335_100608708 | 0.39 |
ZIC5 |
Zic family member 5 |
15642 |
0.18 |
chr17_79485709_79486744 | 0.39 |
RP13-766D20.2 |
|
160 |
0.9 |
chr8_145925356_145925968 | 0.38 |
AF186192.5 |
|
5257 |
0.15 |
chr1_50489142_50489611 | 0.38 |
AGBL4 |
ATP/GTP binding protein-like 4 |
196 |
0.94 |
chrX_114467670_114468385 | 0.37 |
LRCH2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
601 |
0.77 |
chr22_37957123_37957770 | 0.37 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
959 |
0.43 |
chr13_99330080_99330373 | 0.37 |
ENSG00000243366 |
. |
5992 |
0.26 |
chr6_5999099_5999932 | 0.37 |
NRN1 |
neuritin 1 |
7685 |
0.26 |
chr12_20522500_20522819 | 0.36 |
PDE3A |
phosphodiesterase 3A, cGMP-inhibited |
480 |
0.52 |
chr7_5458775_5459294 | 0.36 |
AC093620.5 |
|
424 |
0.46 |
chr1_27357912_27358708 | 0.36 |
FAM46B |
family with sequence similarity 46, member B |
18983 |
0.16 |
chr9_40632604_40633916 | 0.36 |
SPATA31A3 |
SPATA31 subfamily A, member 3 |
67031 |
0.14 |
chr20_36846491_36846985 | 0.36 |
KIAA1755 |
KIAA1755 |
8883 |
0.19 |
chr9_16869822_16870309 | 0.35 |
BNC2 |
basonuclin 2 |
639 |
0.83 |
chr2_142887906_142888379 | 0.35 |
LRP1B |
low density lipoprotein receptor-related protein 1B |
432 |
0.87 |
chr8_97602452_97602809 | 0.35 |
SDC2 |
syndecan 2 |
4015 |
0.32 |
chr8_145022986_145023296 | 0.35 |
PLEC |
plectin |
1903 |
0.2 |
chr9_43685064_43685767 | 0.35 |
CNTNAP3B |
contactin associated protein-like 3B |
505 |
0.86 |
chr19_6076963_6077580 | 0.35 |
CTC-232P5.3 |
|
9307 |
0.15 |
chr21_31311288_31312406 | 0.34 |
GRIK1 |
glutamate receptor, ionotropic, kainate 1 |
3 |
0.99 |
chr1_221057671_221057822 | 0.34 |
HLX |
H2.0-like homeobox |
3162 |
0.25 |
chr12_58129779_58130334 | 0.34 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
1563 |
0.16 |
chr1_95006423_95007262 | 0.34 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
351 |
0.93 |
chr13_20175736_20176974 | 0.33 |
MPHOSPH8 |
M-phase phosphoprotein 8 |
31433 |
0.18 |
chr15_101708121_101708357 | 0.33 |
RP11-505E24.2 |
|
81968 |
0.08 |
chr11_3181654_3181858 | 0.33 |
OSBPL5 |
oxysterol binding protein-like 5 |
867 |
0.55 |
chrX_8699533_8700279 | 0.33 |
KAL1 |
Kallmann syndrome 1 sequence |
321 |
0.94 |
chr7_5469244_5469831 | 0.33 |
TNRC18 |
trinucleotide repeat containing 18 |
4492 |
0.16 |
chr6_26757700_26757961 | 0.33 |
GUSBP2 |
glucuronidase, beta pseudogene 2 |
88787 |
0.07 |
chr2_64586886_64587176 | 0.33 |
ENSG00000264297 |
. |
19138 |
0.23 |
chr17_15851287_15851438 | 0.33 |
ADORA2B |
adenosine A2b receptor |
3131 |
0.25 |
chr1_86047684_86048329 | 0.32 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
1562 |
0.37 |
chr14_105434639_105435137 | 0.32 |
AHNAK2 |
AHNAK nucleoprotein 2 |
9806 |
0.16 |
chr3_159483400_159483608 | 0.32 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
612 |
0.7 |
chr10_116164052_116164623 | 0.32 |
AFAP1L2 |
actin filament associated protein 1-like 2 |
77 |
0.98 |
chr17_1961906_1962057 | 0.32 |
HIC1 |
hypermethylated in cancer 1 |
2377 |
0.14 |
chr5_17219309_17219681 | 0.31 |
BASP1 |
brain abundant, membrane attached signal protein 1 |
1826 |
0.3 |
chr16_81480914_81481100 | 0.31 |
CMIP |
c-Maf inducing protein |
2232 |
0.39 |
chr8_6691754_6692464 | 0.31 |
DEFB1 |
defensin, beta 1 |
43435 |
0.14 |
chr7_19155713_19156221 | 0.31 |
TWIST1 |
twist family bHLH transcription factor 1 |
1328 |
0.36 |
chr11_89027115_89027763 | 0.31 |
TYR |
tyrosinase |
116819 |
0.06 |
chr22_47149775_47150260 | 0.31 |
CTA-29F11.1 |
|
8443 |
0.18 |
chr22_36768110_36768261 | 0.31 |
MYH9 |
myosin, heavy chain 9, non-muscle |
7028 |
0.2 |
chr15_102182223_102182374 | 0.31 |
ENSG00000252614 |
. |
6217 |
0.18 |
chr6_37227035_37227379 | 0.31 |
TBC1D22B |
TBC1 domain family, member 22B |
1659 |
0.28 |
chr12_132111092_132111243 | 0.31 |
ENSG00000212154 |
. |
34441 |
0.2 |
chr4_107956832_107957922 | 0.30 |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
77 |
0.99 |
chrX_85403501_85403824 | 0.30 |
DACH2 |
dachshund homolog 2 (Drosophila) |
37 |
0.99 |
chr12_6493326_6493955 | 0.30 |
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
221 |
0.89 |
chr1_31380173_31380807 | 0.30 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr11_12309017_12309498 | 0.30 |
MICALCL |
MICAL C-terminal like |
810 |
0.62 |
chr9_39817132_39817490 | 0.30 |
SPATA31A2 |
SPATA31 subfamily A, member 2 |
67664 |
0.13 |
chr19_37743129_37743340 | 0.29 |
ZNF383 |
zinc finger protein 383 |
24782 |
0.13 |
chr9_130159461_130160475 | 0.29 |
SLC2A8 |
solute carrier family 2 (facilitated glucose transporter), member 8 |
305 |
0.87 |
chr20_6750709_6750962 | 0.29 |
BMP2 |
bone morphogenetic protein 2 |
2524 |
0.43 |
chr2_144694678_144695023 | 0.29 |
AC016910.1 |
|
210 |
0.96 |
chr7_193532_193958 | 0.29 |
AC093627.12 |
|
435 |
0.67 |
chr11_45067778_45067990 | 0.29 |
PRDM11 |
PR domain containing 11 |
47680 |
0.17 |
chr3_96531977_96533205 | 0.29 |
EPHA6 |
EPH receptor A6 |
834 |
0.76 |
chr6_113970107_113970350 | 0.29 |
ENSG00000266650 |
. |
46111 |
0.16 |
chr19_41699238_41699877 | 0.29 |
CYP2S1 |
cytochrome P450, family 2, subfamily S, polypeptide 1 |
405 |
0.76 |
chr4_90580974_90581125 | 0.29 |
RP11-115D19.1 |
|
21614 |
0.27 |
chr1_161195725_161196723 | 0.29 |
TOMM40L |
translocase of outer mitochondrial membrane 40 homolog (yeast)-like |
130 |
0.84 |
chr20_62318086_62318558 | 0.29 |
RTEL1 |
regulator of telomere elongation helicase 1 |
1370 |
0.24 |
chrX_3061320_3061471 | 0.29 |
ARSF |
arylsulfatase F |
76521 |
0.09 |
chr12_130645923_130646373 | 0.28 |
FZD10 |
frizzled family receptor 10 |
856 |
0.76 |
chr12_104998031_104998607 | 0.28 |
ENSG00000264295 |
. |
12908 |
0.23 |
chr8_122652196_122652655 | 0.28 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
283 |
0.88 |
chr16_73090314_73090763 | 0.28 |
ZFHX3 |
zinc finger homeobox 3 |
3059 |
0.3 |
chr20_50721484_50721986 | 0.28 |
ZFP64 |
ZFP64 zinc finger protein |
273 |
0.95 |
chr9_39287873_39288256 | 0.28 |
CNTNAP3 |
contactin associated protein-like 3 |
28 |
0.99 |
chr15_83952244_83952401 | 0.28 |
BNC1 |
basonuclin 1 |
251 |
0.94 |
chr7_42533030_42533218 | 0.28 |
GLI3 |
GLI family zinc finger 3 |
256466 |
0.02 |
chr11_104034118_104035249 | 0.28 |
PDGFD |
platelet derived growth factor D |
152 |
0.98 |
chr5_176921454_176921726 | 0.28 |
RP11-1334A24.6 |
|
406 |
0.7 |
chr13_52419076_52419304 | 0.28 |
CCDC70 |
coiled-coil domain containing 70 |
16927 |
0.19 |
chr19_49653084_49654050 | 0.28 |
PPFIA3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
2209 |
0.15 |
chr4_122686341_122686757 | 0.28 |
TMEM155 |
transmembrane protein 155 |
33 |
0.94 |
chr5_118406793_118407698 | 0.28 |
DMXL1 |
Dmx-like 1 |
6 |
0.92 |
chr13_80913760_80914290 | 0.28 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
218 |
0.96 |
chr3_125985987_125986785 | 0.28 |
ALDH1L1-AS2 |
ALDH1L1 antisense RNA 2 |
60288 |
0.1 |
chr1_956379_957022 | 0.28 |
AGRN |
agrin |
1197 |
0.27 |
chr22_46933754_46934840 | 0.27 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1230 |
0.46 |
chr22_23487771_23487960 | 0.27 |
RAB36 |
RAB36, member RAS oncogene family |
312 |
0.69 |
chr10_76683945_76684144 | 0.27 |
KAT6B |
K(lysine) acetyltransferase 6B |
85586 |
0.08 |
chr7_20391312_20391720 | 0.27 |
CTA-293F17.1 |
|
20146 |
0.18 |
chr8_87188863_87189124 | 0.27 |
CTD-3118D11.3 |
|
3654 |
0.25 |
chr17_55950685_55950914 | 0.27 |
CUEDC1 |
CUE domain containing 1 |
768 |
0.63 |
chr19_13166621_13166875 | 0.27 |
AC007787.2 |
|
15440 |
0.1 |
chr9_65576390_65577630 | 0.27 |
SPATA31A7 |
SPATA31 subfamily A, member 7 |
67400 |
0.15 |
chr1_33366734_33367013 | 0.27 |
TMEM54 |
transmembrane protein 54 |
86 |
0.96 |
chr17_79370689_79371194 | 0.27 |
RP11-1055B8.6 |
Uncharacterized protein |
1666 |
0.23 |
chr4_6889699_6890105 | 0.27 |
TBC1D14 |
TBC1 domain family, member 14 |
21067 |
0.18 |
chrX_70365452_70365975 | 0.27 |
NLGN3 |
neuroligin 3 |
1001 |
0.39 |
chr22_36310772_36312004 | 0.27 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
23557 |
0.25 |
chr2_223182895_223183757 | 0.27 |
AC010980.2 |
|
330 |
0.89 |
chr1_59043269_59043420 | 0.27 |
TACSTD2 |
tumor-associated calcium signal transducer 2 |
178 |
0.95 |
chr3_79068024_79068175 | 0.27 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
66 |
0.99 |
chr19_49118590_49118741 | 0.27 |
FAM83E |
family with sequence similarity 83, member E |
593 |
0.5 |
chr22_46403073_46403407 | 0.26 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
30231 |
0.1 |
chr4_139160727_139161292 | 0.26 |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
2494 |
0.42 |
chr11_85645675_85646031 | 0.26 |
RP11-90K17.2 |
|
11128 |
0.21 |
chr21_40297838_40298298 | 0.26 |
ENSG00000272015 |
. |
31359 |
0.23 |
chr3_61546098_61546562 | 0.26 |
PTPRG |
protein tyrosine phosphatase, receptor type, G |
1255 |
0.64 |
chr2_45926255_45926465 | 0.26 |
U51244.2 |
|
23745 |
0.22 |
chr11_101453394_101453891 | 0.26 |
TRPC6 |
transient receptor potential cation channel, subfamily C, member 6 |
592 |
0.84 |
chr22_40391903_40392054 | 0.26 |
FAM83F |
family with sequence similarity 83, member F |
1025 |
0.52 |
chr3_149093384_149093535 | 0.26 |
TM4SF1 |
transmembrane 4 L six family member 1 |
40 |
0.97 |
chr7_107641976_107642307 | 0.26 |
LAMB1 |
laminin, beta 1 |
331 |
0.84 |
chr22_50698815_50699396 | 0.26 |
MAPK12 |
mitogen-activated protein kinase 12 |
632 |
0.49 |
chr22_39319816_39319977 | 0.26 |
APOBEC3A |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
28860 |
0.11 |
chr8_77318715_77319027 | 0.26 |
ENSG00000222231 |
. |
140904 |
0.05 |
chr7_70159815_70160908 | 0.25 |
AUTS2 |
autism susceptibility candidate 2 |
33764 |
0.25 |
chr8_494269_494491 | 0.25 |
TDRP |
testis development related protein |
457 |
0.88 |
chr9_34651822_34652525 | 0.25 |
IL11RA |
interleukin 11 receptor, alpha |
16 |
0.94 |
chr1_16479586_16479939 | 0.25 |
RP11-276H7.2 |
|
1944 |
0.21 |
chr15_61520624_61520983 | 0.25 |
RORA |
RAR-related orphan receptor A |
715 |
0.73 |
chr7_83278228_83278460 | 0.25 |
SEMA3E |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
18 |
0.99 |
chr18_34834231_34834654 | 0.25 |
CELF4 |
CUGBP, Elav-like family member 4 |
10275 |
0.2 |
chr18_59617014_59617243 | 0.25 |
RNF152 |
ring finger protein 152 |
55664 |
0.17 |
chr20_10652975_10654015 | 0.25 |
RP11-103J8.1 |
|
81 |
0.96 |
chr4_5039624_5039775 | 0.25 |
STK32B |
serine/threonine kinase 32B |
13470 |
0.23 |
chr18_24236408_24236707 | 0.25 |
KCTD1 |
potassium channel tetramerization domain containing 1 |
808 |
0.43 |
chr12_94638760_94639060 | 0.25 |
PLXNC1 |
plexin C1 |
9384 |
0.19 |
chr2_217555825_217556381 | 0.25 |
AC007563.5 |
|
3084 |
0.22 |
chr9_41433170_41433957 | 0.25 |
SPATA31A5 |
SPATA31 subfamily A, member 5 |
67116 |
0.13 |
chr11_70963231_70963444 | 0.25 |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
286 |
0.94 |
chr1_159111648_159111897 | 0.25 |
AIM2 |
absent in melanoma 2 |
1474 |
0.37 |
chr17_40563503_40563724 | 0.25 |
PTRF |
polymerase I and transcript release factor |
11922 |
0.1 |
chr5_153990189_153990659 | 0.25 |
ENSG00000264760 |
. |
14792 |
0.21 |
chr2_206549618_206550045 | 0.24 |
NRP2 |
neuropilin 2 |
1816 |
0.48 |
chr2_221969079_221969387 | 0.24 |
EPHA4 |
EPH receptor A4 |
398047 |
0.01 |
chr2_114643988_114644188 | 0.24 |
ACTR3 |
ARP3 actin-related protein 3 homolog (yeast) |
3449 |
0.28 |
chrX_136647964_136648621 | 0.24 |
ZIC3 |
Zic family member 3 |
9 |
0.97 |
chr7_90896542_90897161 | 0.24 |
FZD1 |
frizzled family receptor 1 |
3068 |
0.42 |
chr10_71561624_71562119 | 0.24 |
COL13A1 |
collagen, type XIII, alpha 1 |
3 |
0.98 |
chr9_109625885_109626257 | 0.24 |
ZNF462 |
zinc finger protein 462 |
624 |
0.77 |
chr4_54974366_54974565 | 0.24 |
ENSG00000221219 |
. |
4642 |
0.18 |
chr7_100488744_100488895 | 0.24 |
UFSP1 |
UFM1-specific peptidase 1 (non-functional) |
1480 |
0.22 |
chr7_75923830_75924012 | 0.24 |
ENSG00000263569 |
. |
5813 |
0.16 |
chr17_70118510_70118661 | 0.24 |
SOX9 |
SRY (sex determining region Y)-box 9 |
1424 |
0.58 |
chr18_31738936_31739121 | 0.24 |
NOL4 |
nucleolar protein 4 |
63028 |
0.13 |
chr19_39149026_39149198 | 0.24 |
ACTN4 |
actinin, alpha 4 |
10734 |
0.12 |
chr2_158113918_158114875 | 0.24 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr2_1746603_1747283 | 0.23 |
PXDN |
peroxidasin homolog (Drosophila) |
1271 |
0.58 |
chr16_89386869_89387175 | 0.23 |
AC137932.6 |
|
519 |
0.71 |
chr3_151023495_151023662 | 0.23 |
GPR87 |
G protein-coupled receptor 87 |
11162 |
0.16 |
chr5_40411204_40411410 | 0.23 |
ENSG00000265615 |
. |
90887 |
0.09 |
chr17_76879212_76879961 | 0.23 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
9354 |
0.14 |
chr5_55193656_55194061 | 0.23 |
AC008914.1 |
Uncharacterized protein |
30711 |
0.14 |
chr16_16316841_16317488 | 0.23 |
ABCC6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
157 |
0.66 |
chr5_14205024_14205555 | 0.23 |
TRIO |
trio Rho guanine nucleotide exchange factor |
21382 |
0.29 |
chr2_150186573_150186784 | 0.23 |
LYPD6 |
LY6/PLAUR domain containing 6 |
179 |
0.97 |
chr20_43729394_43729952 | 0.23 |
KCNS1 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
77 |
0.96 |
chr12_60546788_60546939 | 0.23 |
ENSG00000264437 |
. |
126225 |
0.06 |
chr17_18139215_18139404 | 0.23 |
FLII |
flightless I homolog (Drosophila) |
10067 |
0.11 |
chr12_54090682_54090833 | 0.23 |
CALCOCO1 |
calcium binding and coiled-coil domain 1 |
17656 |
0.15 |
chr9_139715640_139716017 | 0.23 |
RABL6 |
RAB, member RAS oncogene family-like 6 |
47 |
0.93 |
chr22_30652065_30652410 | 0.23 |
LIF |
leukemia inhibitory factor |
9397 |
0.1 |
chr4_1035336_1035962 | 0.23 |
FGFRL1 |
fibroblast growth factor receptor-like 1 |
29410 |
0.11 |
chr1_31886727_31887046 | 0.23 |
SERINC2 |
serine incorporator 2 |
226 |
0.92 |
chr18_47087336_47087671 | 0.23 |
LIPG |
lipase, endothelial |
39 |
0.97 |
chr1_218522781_218522932 | 0.22 |
TGFB2 |
transforming growth factor, beta 2 |
3279 |
0.27 |
chr8_64133185_64133371 | 0.22 |
ENSG00000241964 |
. |
14191 |
0.24 |
chr2_98962891_98963586 | 0.22 |
AC092675.4 |
|
220 |
0.79 |
chr6_170604225_170605407 | 0.22 |
FAM120B |
family with sequence similarity 120B |
407 |
0.83 |
chr1_220959785_220960305 | 0.22 |
MARC1 |
mitochondrial amidoxime reducing component 1 |
56 |
0.98 |
chr7_28725072_28725301 | 0.22 |
CREB5 |
cAMP responsive element binding protein 5 |
412 |
0.92 |
chr13_99404271_99404634 | 0.22 |
SLC15A1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
456 |
0.86 |
chr19_45843770_45844284 | 0.22 |
KLC3 |
kinesin light chain 3 |
5 |
0.95 |
chr17_27482435_27482735 | 0.22 |
RP11-321A17.4 |
|
15084 |
0.15 |
chr2_150187104_150187520 | 0.22 |
LYPD6 |
LY6/PLAUR domain containing 6 |
261 |
0.96 |
chr9_110250307_110251795 | 0.22 |
KLF4 |
Kruppel-like factor 4 (gut) |
360 |
0.89 |
chr20_47391125_47391276 | 0.22 |
ENSG00000251876 |
. |
35215 |
0.19 |
chr8_23754300_23754592 | 0.22 |
STC1 |
stanniocalcin 1 |
42126 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.1 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.1 | GO:0021508 | floor plate formation(GO:0021508) |
0.0 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.3 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0048343 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.0 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.2 | GO:0051323 | metaphase(GO:0051323) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.3 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.6 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.8 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0060536 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.4 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.2 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.3 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 0.4 | GO:0038061 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.0 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.0 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.0 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.5 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.0 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.0 | 0.2 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.1 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.0 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.5 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.0 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |